Family Planning for People with Multiple Sclerosis in Saudi Arabia: an Expert Consensus
| Autor: | Yaser Al Malik, I. Althubaiti, Edward Cupler, Eman Nassim Ali, Jameelah Saeedi, Ahmed ElBoghdady, Nuha M. Alkhawajah, Mohammed Al Jumah, Marinella Clerico, Ahmed Hassan, Reem F. Bunyan, Saeed Bohlega |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Pregnancy Evidence-based practice business.industry Psychological intervention Breastfeeding Review Article medicine.disease Family life 03 medical and health sciences 0302 clinical medicine Natalizumab Family planning Family medicine medicine 030212 general & internal medicine Neurology (clinical) Neurology. Diseases of the nervous system Glatiramer acetate business RC346-429 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Multiple Sclerosis International Multiple Sclerosis International, Vol 2021 (2021) |
| ISSN: | 2090-2662 2090-2654 |
| Popis: | More than half of all patients with multiple sclerosis (MS) in the Kingdom of Saudi Arabia (KSA) are women of childbearing age. Raising a family is an important life goal for women in our region of the world. However, fears and misconceptions about the clinical course of relapsing-remitting MS (RRMS) and the effects of disease-modifying drugs (DMDs) on the foetus have led many women to reduce their expectations of raising a family, sometimes even to the point of avoiding pregnancy altogether. The increase in the number of DMDs available to manage RRMS and recent studies on their effects in pregnancy have broadened management options for these women. Interferon beta now has an indication in Europe for use during pregnancy (according to clinical need) and can be used during breastfeeding. Glatiramer acetate is a further possible option for women with lower levels of RRMS disease activity who are, or about to become, pregnant; natalizumab may be used up to 30 weeks in patients with higher levels of disease activity. Where possible, physicians need to support and encourage women to pursue their dream of a fulfilling family life, supported where necessary by active interventions for RRMS that are increasingly evidence based. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text